Impact of sensitivity of human leucocyte antigen antibody detection by Luminex technology on graft loss at 1 year

Clinical Kidney Journal

Volumn 6, Issue 3, 2013, Pages 283-286

  Szatmary, Peter ^a   Jones, James ^a   Hammad, Abdul ^a   Middleton, Derek ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

crossmatch; HLA; Luminex; renal transplantation

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN;

ADULT; ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HLA MATCHING; HUMAN; HUMAN TISSUE; KIDNEY DONOR; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL;

EID: 84878593600     PISSN: 20488505     EISSN: 20488513     Source Type: Journal    
DOI: 10.1093/ckj/sft037     Document Type: Article

References (16)

1. Patel R, Teresaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969; 280: 735-739
2. Terasaki PI, McClelland JD. Antibody response to homografts VIII. Relation of mouse hemagglutinins and cytotoxins. J Exp Med 1963; 117: 675-690
3. Scornik JC, Brunson ME, Schaub B et al. The crossmatch in renal transplantation. Transplantation 1994; 57: 621-625
4. Karpinski M, Rush D, Jeffery J, et al. Flow cytometric cross-matching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch. J Am Soc Nephrol 2001; 12: 2807-2814
5. Gibney EM. Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification. Nephrol Dial Transplant 2006; 21: 2625-2629
6. Tait BD, Hudson F, Cantwell L et al. Review article: Luminex technology for HLA antibody detection in organ transplantation. Nephrology 2009; 14: 247-254
7. Lee PC, Ozawa M, Hung CJ et al. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation. Transplant Proc 2009; 41: 95-98
8. Bielmann D, Hönger G, Lutz D et al. Pretransplant risk assessment in renal allograft recipients using virtual crossmatch-ing. Am J Transplant 2007; 7: 626-632
9. Patel AM, Pancoska C, Mulgaonkar S et al. Renal transplantation in patients with pre-transplant donor-specific antibodies and negative flow cytometry crossmatches. Am J Transplant 2007; 7: 2371-2377
10. Terasaki PI, Ozawa M, Castro R. Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. Am J Transplant 2007; 7: 408-415
11. Susal C, Ovens J, Mahmoud K et al. No association of kidney graft loss with human leukocyte antigen antibodies detected exclusively by sensitive Luminex single-antigen testing: a Collaborative Transplant Study report. Transplantation 2011; 91: 883-887
12. van den Berg-Loonen EM, Billen EVA, Voorter CEM et al. Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients. Transplantation 2008; 85: 1086-1090
13. Phelan D, Mohanakumar T, Ramachandran S et al. Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assay. Hum Immunol 2009; 70: 584-588
14. Otten HG, Verhaar MC, Borst HP et al. Pretransplant donor-specific HLA class-I and-II antibodies are associated with an increased risk for kidney graft failure. Am J Transplant 2012; 12: 1618-1623
15. Chen G, Sequeira F, Tyan DB. Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads. Hum Immunol 2011; 72: 849-858
16. Llorente S, Boix F, Eguia J et al. C1q-fixing human leukocyte antigen assay in immunized renal patients: correlation between Luminex SAB-C1q and SAB-IgG. Transplant Proc 2012; 44: 2535-2537